Treatment of High-Risk Neuroblastoma
Children · 28.07.2023 · 10 (8) · 1302
DOI: 10.3390/children10081302 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Children, online erschienen am 28.07.2023. Verfasst von Julie Krystal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Zucker Hofstra School of Medicine, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY 11040, USA. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
High-risk neuroblastoma is a highly aggressive solid tumor that most commonly presents in early childhood. Advances in treatment through decades of clinical trials and research have led to improved outcomes. This review provides an overview of the current state of treatment for high-risk neuroblastoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zucker Hofstra School of Medicine, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY 11040, USA.
- Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Julie Krystal, Jennifer H Foster
Zitieren
APA
Krystal, J., & Foster, J. H. (2023). Treatment of High-Risk Neuroblastoma. Children, 10(8), 1302. https://doi.org/10.3390/children10081302
Vancouver
Krystal J, Foster JH. Treatment of High-Risk Neuroblastoma. Children. 2023;10(8):1302. doi:10.3390/children10081302
BibTeX
@article{Krystal2023,
author = {Krystal, Julie and Foster, Jennifer H},
title = {Treatment of High-Risk Neuroblastoma},
journal = {Children},
year = {2023},
volume = {10},
number = {8},
pages = {1302},
doi = {10.3390/children10081302}
}
EUVIMED